Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04218799 · ClinicalTrials.gov registry record · Phase 4

Human Microbiome and Healthcare Associated Infections - Nursing Home Dwelling Older Veterans

A Phase 4 study, sponsored by University of Maryland, Baltimore.

Completed
Registry status
Phase 4
Development phase
19
Enrollment target

NCT04218799 is a Phase 4 study that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 19 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04218799, a Phase 4 study, has completed, sponsored by University of Maryland, Baltimore.

COMPLETED
Registry status
Phase 4
Development phase
19 participants
Enrollment target

Study Summary

The purpose of the research is to find out the effect of commonly used topical antibiotics on the bacteria that live in the nose, throat and on the skin of older adults. In addition, the investigators want to determine if these topical antibiotics affect how bacteria are spread in Community Living Centers of the VA Maryland Health Care System.

Interventions

  • DRUG Intranasal Mupirocin and Topical Chlorhexidine

Trial Details

FieldValue
Enrollment Target 19 participants
Start Date 2014-08-12
Est. Completion 2015-09-22
Phase Phase 4

Sponsor

University of Maryland, Baltimore

560 total trials

What the Registry Record Tells You About NCT04218799

The ClinicalTrials.gov registry entry for NCT04218799 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Intranasal Mupirocin and Topical Chlorhexidine is the first listed.

NCT04218799 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04218799 about?

NCT04218799 is a clinical study titled "Human Microbiome and Healthcare Associated Infections - Nursing Home Dwelling Older Veterans". The purpose of the research is to find out the effect of commonly used topical antibiotics on the bacteria that live in the nose, throat and on the skin of older adults. In addition, the investigators want to determine if these topical antibiotics affect how bacteria are spread in Community Living C...

What is the current status of trial NCT04218799?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 19 participants. The study started on 2014-08-12. Estimated completion is 2015-09-22.

What interventions are being tested in trial NCT04218799?

The interventions under investigation include: Intranasal Mupirocin and Topical Chlorhexidine (DRUG).

Who is sponsoring clinical trial NCT04218799?

This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.